Detalhe da pesquisa
1.
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment.
Hematol Oncol
; 40(4): 734-742, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618655
2.
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents.
Eur J Haematol
; 108(6): 449-459, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35156731
3.
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement.
Acta Haematol
; 144(6): 688-692, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34130278
4.
Clinical and Molecular Insights in Erythropoiesis Regulation of Signal Transduction Pathways in Myelodysplastic Syndromes and ß-Thalassemia.
Int J Mol Sci
; 22(2)2021 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33467674
5.
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia.
Eur J Haematol
; 105(1): 47-55, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32145118
6.
Acute Myeloid Leukemia Mutations: Therapeutic Implications.
Int J Mol Sci
; 20(11)2019 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31163594
7.
The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.
BMC Cancer
; 17(1): 523, 2017 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28779753
8.
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant.
Hematol Oncol
; 39(4): 580-583, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963566
9.
Detection of Cancer Stem Cells in Normal and Dysplastic/Leukemic Human Blood.
Methods Mol Biol
; 2777: 163-176, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38478343
10.
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progression.
Adv Biol Regul
; 91: 101014, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242820
11.
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.
Blood
; 118(12): 3273-9, 2011 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21791425
12.
Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire.
Front Immunol
; 14: 1111419, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36865545
13.
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes.
Clin Epigenetics
; 15(1): 27, 2023 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803590
14.
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study.
Cancer Med
; 12(10): 11838-11848, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999931
15.
Exploring the rationale for red cell transfusion in myelodysplastic syndrome patients: emerging data and future insights.
Expert Rev Hematol
; 15(5): 411-421, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549626
16.
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia.
Blood Adv
; 6(1): 87-99, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34535017
17.
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia.
Cancer Med
; 11(3): 618-629, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34970853
18.
Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients.
J Blood Med
; 12: 1019-1030, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34887690
19.
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients.
Leuk Res
; 101: 106497, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33385697
20.
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters.
Front Immunol
; 12: 804988, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35173709